We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Hologic and Aloka Announce Distribution Agreement

By HospiMedica staff writers
Posted on 26 Nov 2003
A three-year distribution agreement gives Hologic (Bedford, MA, USA) exclusive distribution rights in the United States to ultrasound products for breast imaging to be manufactured by Aloka Company Ltd. (Tokyo, Japan) and customized to Hologic's specifications.

According to the agreement, Aloka will manufacture a joint-label, high-performance, fully functional diagnostic ultrasound system optimized for women's imaging, with emphasis on finding and diagnosing abnormalities within the breast. The system will incorporate Aloka's proprietary ProSound technologies, including digital pure beam imaging, tissue harmonic echo, 3D color Doppler, a 12-bit analog-to-digital converter to enable higher contrast resolution, and an integrated DICOM compatible image management.

"Our system specifications focused on the highest image quality, a versatile feature-set, simplicity of use for technologists and physicians, and affordable pricing for women's imaging suites that are suffering from overall reimbursement pressures,” said Jack Cumming, chairman and CEO of Hologic. "In addition and most importantly, Aloka shares our passion for improving healthcare for women.”




Related Links:
Hologic
Aloka
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Head Rest
Medifa 61114_3
New
Mammo DR Retrofit Solution
DR Retrofit Mammography

Channels

Surgical Techniques

view channel
Image: The novel approach combining MRI, fluid dynamics, and custom algorithms predicts brain cancer recurrence sites (photo courtesy of AdobeStock)

Novel Method Uses Interstitial Fluid Flow to Predict Where Brain Tumor Can Grow Next

Glioblastoma is one of the most aggressive brain cancers, with patients surviving on average only 15 months after diagnosis. Surgery and radiation can temporarily control the tumor, but the disease almost... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more